China Wah Yan Healthcare Limited provided earnings guidance for the year ended December 31, 2015. The board of directors of the company announced that based on assessment by the board of the latest available unaudited consolidated management accounts of the group, the group's loss for the year ended December 31, 2015 is expected to be increased substantially as compared to the loss of HKD 42 million for the year ended December 31, 2014, due to, among other factors: impairment losses on the accounts receivable and/or decrease in the Group's turnover from the operation of the Group's medical centres specializing in the diagnosis and treatment of tumour in The People's Republic of China; the potential tax provision as a result of the Group's restructuring of its interest in certain healthcare related investments/assets; and the decrease in the fair value of the Group's financial and capital assets.